Shanghai Junshi Biosciences is a biopharmaceutical company based in Shanghai that discovers, develops and commercialises biologic medicines, chiefly monoclonal antibodies for cancer and inflammatory disease. Its antibody therapies are used by hospitals and clinicians treating patients with cancers such as melanoma, nasopharyngeal carcinoma and lung cancer, and it also pursues antiviral and autoimmune treatments. The company carries out research and clinical development in China and works with partners abroad to bring its medicines to wider markets.
The shares are listed on the Hong Kong Stock Exchange in Hong Kong under the code 1877, and the price on this page is in Hong Kong dollars (HKD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #1415 of 2611 on the Hong Kong Stock Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Hong Kong yet.
TrendWeak
42/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-16.4%
From 52-week high-40.6%
MomentumWeak
27/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-10.5%
6-month return-39.9%
12-month, skipping last month-41.5%
Stability (higher is calmer)Fair
53/100
Typical risk for this exchange.
See the numbers →
Volatility, 1 year (lower is calmer)54.0%
Worst drawdown, 1 year (smaller is calmer)-46.9%
LiquidityStrong
86/100
Trades actively.
See the numbers →
Avg daily value traded43.35M HKD
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Hong Kong when fundamentals data for this market is added. All Hong Kong stocks.
52-wk range 15.25 – 30.80Daily closes, split-adjusted
Signals
50-day average18.11
200-day average20.56
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.89
Technical summary
Daily
Bearish
2 bullish · 4 neutral · 10 bearish
Weekly
Strongly bearish
0 bullish · 1 neutral · 11 bearish
Monthly
Strongly bearish
0 bullish · 1 neutral · 7 bearish
Moving averages (daily)
SMA 10
16.98
Bullish
EMA 10
17.01
Bullish
SMA 20
17.73
Bearish
EMA 20
17.38
Bearish
SMA 50
18.11
Bearish
EMA 50
17.94
Bearish
SMA 100
18.09
Bearish
EMA 100
18.79
Bearish
SMA 200
20.56
Bearish
EMA 200
20.05
Bearish
Oscillators (daily)
RSI (14)
46.99
Neutral
MACD (12, 26)
-0.42
Bearish
Momentum (12)
-4.81
Bearish
Stochastic %K (14)
37.76
Neutral
Williams %R (14)
-62.24
Neutral
CCI (20)
-59.88
Neutral
Pivot points (classic, last session)
S3
15.81
S2
16.19
S1
16.70
Pivot
17.08
R1
17.59
R2
17.97
R3
18.48
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in HKD. Educational only, not financial advice.
